Stockscreener 앱 받기
26.03
2.11%
-0.56
시간 외 거래:
27.20
1.17
+4.49%
Parabilis Medicines Inc 주식(PBLS)의 최신 뉴스
PBLS | Parabilis Medicines, Inc. Common Insider Trading - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
RA Capital funds lift Parabilis Medicines (PBLS) common equity exposure - Stock Titan
Parabilis Medicines (PBLS) director converts preferred stock into common around IPO - Stock Titan
Parabilis (PBLS) director-linked LLC makes open-market buy of 12,500 shares - Stock Titan
Parabilis Medicines (PBLS) director converts Series F preferred into common in IPO - Stock Titan
Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline - Yahoo Finance
Regeneron-backed Parabilis surges after record-setting IPO - MSN
Parabilis Medicines (PBLS) Stock Chart and Price History 2026 - MarketBeat
PBLS News Today | Why did Parabilis Medicines stock drop today? - MarketBeat
Parabilis Medicines prices upsized IPO at $19 per share - MSN
Parabilis Medicines prices upsized IPO at $20 per share - MSN
Current ratio of Parabilis Medicines, Inc. – NASDAQ:PBLS - TradingView
Parabilis Medicines (PBLS) Stock Price, News & Analysis - MarketBeat
Parabilis upsizes IPO seeking to raise more than $600M - MSN
PBLS SEC FilingsPARABILIS MEDICINES INC 10-K, 10-Q, 8-K Forms - Stock Titan
Rx Rundown: Incyte, Parabilis Medicines, Pfizer and more - Medical Marketing and Media
PBLS Price Today: Parabilis Medicines, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
PBLS: Static price chart | Parabilis Medicines, Inc. | US6989551014 - marketscreener.com
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? - Yahoo Finance
Parabilis Soared 58% in the Biggest Biotech IPO on Record. Is It Too Late to Buy the Stock? - The Motley Fool
Regeneron backed Parabilis seeks up to $476M in US IPO - MSN
Parabilis Medicines (PBLS) 10K Form and Latest SEC Filings 2026 - MarketBeat
Parabilis Medicines, Inc. (PBLS) Stock Price Today & Analysis - Gotrade
Parabilis (NASDAQ: PBLS) reports RA Capital-linked grant of 20,215 stock options - Stock Titan
Parabilis Medicines (PBLS) director receives 20,215 stock options at $20 strike - Stock Titan
Parabilis (PBLS) awards director 20,215 options at $20 strike - Stock Titan
Parabilis (PBLS) director granted 20,215 stock options at $20 strike - Stock Titan
PBLS Price History for Parabilis Medicines Stock - Barchart.com
Parabilis Medicines (PBLS) director receives stock options for 20,215 shares at $20 - Stock Titan
[Form 4] Parabilis Medicines, Inc. Insider Trading Activity - Stock Titan
Parabilis Medicines closes $770.5m IPO, Regeneron investment By Investing.com - Investing.com
Parabilis Medicines closes $770.5 million IPO and concurrent private placement - Investing.com Canada
Parabilis Medicines Raises About $75 Million in Private Placement With Regeneron at 90% of IPO Price - TradingView
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Regeneron backs Parabilis (PBLS) with IPO private placement and new charter - Stock Titan
Is biotech back? Kardigan tries on a $373 million IPO following Parabilis' success - The Business Journals
Parabilis Medicines Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - Moomoo
Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Parabilis Medicines, Inc.Common Stock (Nasdaq:PBLS) Stock Quote - The Chronicle-Journal
Parabilis Medicines Rings the Closing Bell - Nasdaq
How to Play PBLS Stock After the Parabilis IPO - Barchart.com
Parabilis Is Now the Largest VC-Backed Biotech IPO - Morningstar
Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ - Pharmaceutical Executive
HBM Healthcare Investments benefits from successful IPO of Parabilis Medicines - TradingView
Parabilis Medicines, Inc. (PBLS): IPO Prices Above Range, Opens with Massive First-Day Pop - Smartkarma
Parabilis Medicines Shares Rocket Following Record Biotech IPO - WSJ
Parabilis Medicines’ Quest to Drug the Undruggable Picks Up $745M From Upsized IPO - MedCity News
Parabilis now the largest VC-backed biotech IPO - Yahoo Finance
Market Today: GM Expands Battery Business, Parabilis Medicines P - GuruFocus
Parabilis soars to $3.7B market cap after first day on NASDAQ - FirstWord Pharma
Parabilis Medicines, Inc.(NasdaqGS: PBLS) added to NASDAQ Composite Index - marketscreener.com
Parabilis Breaks Kailera’s Short-Lived Biopharma IPO Record - Citeline News & Insights
Parabilis Medicines (PBLS) Prices Shares Above Target Range - GuruFocus
Parabilis sets a record with a $670M biotech IPO - BioPharma Dive
Parabilis (NASDAQ: PBLS) IPO $670M at $20; Regeneron to buy $75M concurrent - Stock Titan
Goodwin, Covington Lead Parabilis' $670M Upsized IPO - Law360
Cancer Drugmaker Parabilis Surges 58% in US Trading Debut - Bloomberg
Parabilis sets biotech IPO record with $670M raise - MSN
Parabilis Medicines stock opens 67% above IPO price - Investing.com
Regeneron-backed Parabilis rises on market debut (REGN:NASDAQ) - Seeking Alpha
Parabilis Medicines raises record $670 million in biotech IPO - Yahoo Finance
Parabilis takes top spot, pricing largest biopharma IPO at $670M - BioWorld News
Parabilis Medicines sets biotech record with $670m IPO - Yahoo Finance
2.60%
0.94%
자본화:
|
볼륨(24시간):